Results 131 to 140 of about 34,235 (247)
ABSTRACT Introduction/Aims The patient experience of Becker muscular dystrophy (BMD) is not well understood, making it difficult to evaluate the conceptual relevance of proposed patient‐reported outcome (PRO) measures. This study aimed to conceptualize the patient experience of BMD and evaluate content validity and perceptions of meaningful changes of ...
Abby Bronson +6 more
wiley +1 more source
This review summarizes that medicinal and edible homologous TCMs—such as Mongolian milkvetch root, common turmeric rhizome, and Angelica—alleviate chronic inflammatory diseases (IBD, RA, and AS) by inhibiting M1 and promoting M2 macrophage polarization, providing a theoretical basis for inflammation therapy and daily dietary intervention.
Cheng Zhang +15 more
wiley +1 more source
Background Rhabdomyolysis is a potentially fatal disorder that occurs due to various causes. Therefore, the aim of this meta-analysis was to identify the underlying causes, evaluate the treatment options, and determine the mortality and kidney outcomes ...
Hany A. Zaki +5 more
doaj +1 more source
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
Franziska Roth‐Walter +20 more
wiley +1 more source
Abstract Parenteral iron is widely prescribed by medical practitioners, with more than 600 000 outpatient prescriptions dispensed in 2025 through the Australian Pharmaceutical Benefits Scheme. While intravenous iron has transformed the management of iron deficiency, hypophosphataemia is now recognised as a common complication, with incidences reported ...
Brenda Ta +3 more
wiley +1 more source
Treatment Goals for Primary Biliary Cholangitis, an Australian Perspective
ABSTRACT Primary biliary cholangitis (PBC) is an autoimmune liver disease that targets the small intrahepatic bile ducts with diagnosis based on elevated serum alkaline phosphatase (ALP) levels and the presence of anti‐mitochondrial antibodies. Untreated, it may run a progressive course to cirrhosis and hepatic decompensation, at which point liver ...
Simone I. Strasser +6 more
wiley +1 more source
Effect of C60 Fullerene on Muscle Injury-Induced Rhabdomyolysis and Associated Acute Renal Failure [PDF]
Yuriy Prylutskyy,1 Dmytro Nozdrenko,1 Olexandr Omelchuk,2 Svitlana Prylutska,3 Olexandr Motuziuk,1,2 Vasil Soroсa,1 Igor Vareniuk,1 Viktoria Stetska,1 Kateryna Bogutska,1 Uwe Ritter,4 Jacek Piosik5 1ESC ”institute of Biology and Medicine”, Taras ...
Vareniuk I +10 more
core
Targeting progressive multiple sclerosis: Toward mechanism‐informed precision medicine
Abstract Multiple sclerosis has undergone a therapeutic revolution over the past three decades. Randomized clinical trials and real‐world data demonstrate that modern disease‐modifying therapies substantially reduce relapse rates and acute inflammatory activity detected by magnetic resonance imaging (MRI).
Fredrik Piehl +3 more
wiley +1 more source
Clarithromycin-induced rhabdomyolysis: a case report
Giuseppe Pasqualetti, Giacomo Bini, Sara Tognini, Antonio Polini, Fabio MonzaniGeriatrics Unit, Department of Internal Medicine, University Hospital of Pisa, Pisa, ItalyAbstract: Rhabdomyolysis is a clinical and laboratory syndrome that is caused by ...
Pasqualetti G +4 more
doaj
Primary aldosteronism with hypokalemic rhabdomyolysis: a case report and review of the literature
Background Hypokalemic rhabdomyolysis is a rare clinical manifestation of primary aldosteronism, making its diagnosis challenging, particularly when it becomes the primary presenting symptom.
Pingan Shi, Chao Wang, Yuanjun Lyu
doaj +1 more source

